BlackRock Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

BlackRock Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$122K	Sell	6,978 -231	-3%	-$4.43K	﹤0.01%	2951
2016 Q3	$172K	Buy	7,209 +516	+8%	+$9.72K	﹤0.01%	2762
2016 Q2	$107K	Buy	6,693 +192	+3%	+$3.44K	﹤0.01%	2936
2016 Q1	$136K	Buy	6,501 +601	+10%	+$10.7K	﹤0.01%	2767
2015 Q4	$159K	Sell	5,900 -2,403	-29%	-$65.5K	﹤0.01%	2697
2015 Q3	$231K	Buy	8,303 +928	+13%	+$29.2K	﹤0.01%	2639
2015 Q2	$181K	Buy	7,375 +6,095	+476%	+$126K	﹤0.01%	2849
2015 Q1	$23K	Hold	1,280	–	–	﹤0.01%	3430
2014 Q4	$24K	Buy	+1,280	New	+$15.2K	﹤0.01%	3471

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's LJPC Position: Q4 2016 in Review

BlackRock Advisors reduced its La Jolla Pharmaceutical Company (LJPC) stake by 3.2% in Q4 2016, selling an estimated $4.43K and leaving 6,978 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

BlackRock Advisors first reported a position in LJPC in Q4 2014 and has held it in 9 quarters since. The position peaked at $231K in Q3 2015. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

BlackRock Advisors held 6,978 shares of La Jolla Pharmaceutical Company worth $122K as of Q4 2016.
BlackRock Advisors sold 231 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $4.43K.
La Jolla Pharmaceutical Company made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2951 holding.
BlackRock Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's La Jolla Pharmaceutical Company position peaked at $231K in Q3 2015.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.